Promising data were also obtained for SS, where serum miR‐92b-3p constituted a robust marker for discriminating patients with SS from other STS patients and was elevated in EVs compared with AGO2‐positive fractions (Uotani et al, 2017). The gene discussed is AGO2; the disease is synovial sarcoma.